Lauren Merendino Day One Biopharmaceuticals, Inc. (DAWN) insider trading activity

Lauren Merendino is Chief Commercial Officer of Day One Biopharmaceuticals, Inc.. Currently has a direct ownership of 50,809 shares of DAWN, which is worth approximately $447,119. The most recent transaction as insider was on Nov 17, 2025, when has been sold 3,726 shares (Common Stock) at a price of $8.91 per share, resulting in proceeds of $33,198. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 50.8K

21.17% 3M change

n/a 12M change

Total Value Held $447,119

Lauren Merendino Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 17 2025	SELL Open market or private sale	$33,198 $8.91 p/Share	3,726 Reduced 6.83%	50,809 Common Stock
Nov 15 2025	BUY Exercise of conversion of derivative security	-	10,536 Added 16.19%	54,535 Common Stock
Aug 18 2025	SELL Open market or private sale	$25,495 $6.77 p/Share	3,766 Reduced 8.24%	41,931 Common Stock
Aug 15 2025	BUY Exercise of conversion of derivative security	-	10,536 Added 18.74%	45,697 Common Stock
May 16 2025	SELL Open market or private sale	$24,583 $6.26 p/Share	3,927 Reduced 10.05%	35,161 Common Stock
May 15 2025	BUY Exercise of conversion of derivative security	-	10,536 Added 21.23%	39,088 Common Stock

Also insider at

MYOV

Myovant Sciences Ltd. Healthcare

Chief Commercial Officer

EPIX

ESSA Pharma Inc. Healthcare